Accessibility Menu
Emv Capital Plc logo

Emv Capital Plc(LSE) NSCI

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2013)-97%
5 Year-51%
1 Year+16%
1 Month+1%
N/A
Emv Capital Plc last closing stock price
MetricPriceDate
Last closeGBX 53.502026-08-21
Emv Capital Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%GBX 53.502026-08-14
1 month+0.94%GBX 53.002026-07-22
3 month+15.05%GBX 46.502026-05-22
Year to date-6.14%GBX 57.002025-12-31
1 year+16.3%GBX 46.002025-08-21
3 year-11.57%GBX 60.502023-08-22
5 year-51.36%GBX 110.002021-08-20
Since inception-96.76%GBX 16.502013-09-16

Emv Capital Plc Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Sep 30, 2024

NSCI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Emv Capital Plc

NetScientific plc operates as a venture capital entity, focusing on investments in sustainability, advanced technology, and innovative biomedical and healthcare solutions. The company targets digital health, diagnostics, and therapeutics, aiming to improve health outcomes for individuals with chronic diseases.

Products and Services
  • Investments in digital health technologies and data analytics
  • Focus on diagnostics and therapeutic innovations
  • Support for wearable technologies and medical devices
Growth Outlook
  • Active investment strategy in established European and U.S. markets
  • Potential for significant returns in the growing healthcare sector
  • Commitment to securing controlling interests in key subsidiaries
Financial Highlights
  • Market capitalization of approximately £12.72 million
  • Recent stock price range between 48.0 and 80.5 GBp
  • Trailing twelve months revenue of £2.5 million
NetScientific plc is strategically positioned within the biotechnology sector, leveraging its expertise to identify and nurture high-potential companies. The focus on digital health and innovative technologies aligns with global trends towards improved healthcare solutions. With a commitment to substantial investments, the company aims to drive growth and enhance shareholder value. The recent stock performance indicates a volatile market presence, reflecting both challenges and opportunities in the biotechnology landscape. Investors may find NetScientific's approach to venture capital appealing, particularly in light of the increasing demand for healthcare innovations.
AI Generated • Aug 19, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Ilian Petkov Iliev, PhD

Website

www.netscientific.net

Headquarters

London, E14 5AB, GB

NSCI Financials

Key Financial Metrics (TTM)

Gross Margin

78.51%

Operating Margin

-66.33%

Net Income Margin

-0.73%

Return on Equity

-0.14%

Return on Capital

N/A

Return on Assets

-0.11%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Emv Capital Plc Performance Analysis

Emv Capital Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,004,000-9.3%
20232023-12-31USD 1,445,00043.9%
20242024-12-31USD 2,450,00069.6%
20252025-12-31USD 2,866,00017.0%
Emv Capital Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.145.2%
20232023-12-31USD -0.11-19.1%
20242024-12-31USD -0.1312.1%
20252025-12-31USD -0.00-99.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SNG.LSynairgen plc
£0.01+0.00%
AVO.LAdvanced Oncotherapy plc
£0.02-9.09%
YGEN.LYourgene Health Plc
£0.01-0.47%
TCF.LTheracryf Plc
£0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.77+0.10%
IBITiShares Bitcoin Trust
$43.68+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$10.41+0.06%
MARAMara Holdings
$11.26+0.01%

Questions About NSCI

What is the current price of Emv Capital Plc?

Emv Capital Plc is trading at N/A per share.

What is the 52-week range for Emv Capital Plc?

Over the past 52 weeks, Emv Capital Plc has traded between N/A and N/A.

How much debt does Emv Capital Plc have?

As of the most recent reporting period, Emv Capital Plc reported total debt of $2.60M.

How much cash does Emv Capital Plc have on hand?

Emv Capital Plc reported $511.00K in cash and cash equivalents in its most recent financial results.

What is Emv Capital Plc’s dividend yield?

Emv Capital Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services